FDA Updates BioZorb Recall, Citing Over 250 Patient Injuries

The FDA has reported 252 injuries linked to Hologic's BioZorb radiographic markers, which are implanted in breast and other soft tissues. This update follows Hologic's advisory nearly two years ago for customers to cease using the devices due to adverse events. Healthcare providers are now advised to monitor patients who have received these implanted markers.